Complementing these results, our analysis of RNA-Seq data in BALF from severe COVID-19 patients showed an upregulation in the Epstein-Barr virus infection pathway, which is known to involve TLR2-MyD88 signalling. The gene discussed is MYD88; the disease is Epstein-Barr virus infection.